Phase II study of DZD9008 in lung cancer patients with EGFR exon 20 insertion mutation
| Title | Phase II study of DZD9008 in lung cancer patients with EGFR exon 20 insertion mutation |
|---|---|
| Description | A phase II, single-arm, multicenter study to evaluate the antitumor efficacy, safety, tolerability and pharmacokinetics of DZD9008 in patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR exon 20 insertion mutations study |
| Organism | Homo |
| Data Type | Other Type of Metabolome Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA010976 |
| Release Date | 2022-09-01 |
| Submitter | mengzhao wang (mengzhaowang@sina.com) |
| Organization | Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College |
| Submission Date | 2022-08-31 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX001726-01 | PK data in WK6 study | 103 | Other Type of Metabolome Data | 143.6 KB | csv | 0 | Controlled |